8,68USD

0,00USD

0,00%

21:59:10

BTT

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt für 0 Euro bei ZERO ordern (zzgl. Spreads)

ISIN: KYG2851K1206

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt Times and Sales (NAS)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt

Weitere Meldungen

01:13		Is Rigetti Computing Stock a Buy Right Now?
01:09		'He hid the a la carte menu': Who should pay on the first date
01:09		Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook
01:01		Why CarMax Stock Rebounded on Thursday
01:00		Asics could run faster if it unshackled Onitsuka Tiger
01:00		CSE Global’s sell-off over boardroom clash overblown: analysts
01:00		SpaceX Just Identified a $22.7 Trillion Enterprise AI Market. These 2 AI Stocks Are Already Inside the Empire.
00:39		EU summit: Leaders discuss Ukraine, global issues
00:30		Here's How Much $1000 Invested In Royal Caribbean Group 5 Years Ago Would Be Worth Today
00:25		2 Reasons Investors Should Not Short SpaceX Stock
00:15		$100 Invested In Anglogold Ashanti 5 Years Ago Would Be Worth This Much Today
00:13		Stock Market Today, June 18: Comcast Falls as Cable Pressure Builds Before July Earnings
00:04		EU set to remove barriers to banks’ cross-border capital flows
00:04		EU set to remove barriers to banks’ cross-border capital flows
00:01		SpaceX plots $20bn bond deal after record IPO
00:01		SpaceX plots $20bn bond deal after record IPO
00:01		$1000 Invested In Valero Energy 10 Years Ago Would Be Worth This Much Today
00:00		Waymo Issues Another Recall, This Time Over Highway Construction Zones
00:00		SpaceX warns EU satellite plan risks undermining connectivity in Ukraine
18.06.26		The Washington Outlet NOTUS Won’t Be ‘The Star’ After All
18.06.26		SpaceX Had The Best IPO In History—Now Comes The Hard Part
18.06.26		Stock Market Today, June 18: Netflix Edges Higher as Investors Weigh Pricing Upside Before Earnings
18.06.26		Holding SpaceX Since The IPO? Why I'd Use The Strength To Sell
18.06.26		Are You a Recent College Graduate Who Moved Back Home? We Want to Hear From You.
18.06.26		SpaceX options volume explodes as trading kicks off. Here is a low-risk strategy to play the massive surge.
18.06.26		If You Invested $100 In Centene Stock 20 Years Ago, You Would Have This Much Today
18.06.26		International Recap, June 18: Hawkish Central Bank Signals Pressure FTSE 100, While Risk-On Mood Lifts Nikkei 225
18.06.26		Ethereum Dumps Below $1,700 But Hits All-Time Highs In Users, Transactions: What Is Going On?
18.06.26		$1000 Invested In American Express 5 Years Ago Would Be Worth This Much Today
18.06.26		Nebius Is Up 210% This Year. Here's Why There's Still Room for More Upside in 2026.
18.06.26		Stock Market Today, June 18: Marvell Technology Surges on Price Target Hike
18.06.26		Here's How Much You Would Have Made Owning Exxon Mobil Stock In The Last 5 Years
18.06.26		Index Investors: Here's How Much SpaceX Stock You're About to Own
18.06.26		Why Leidos Stock Plummeted This Week
18.06.26		SpaceX Just Went Public. Here's What Smart Investors Are Doing With SPCX Stock Right Now.
18.06.26		$1000 Invested In Ameriprise Financial 20 Years Ago Would Be Worth This Much Today
18.06.26		Deutsche Bank: Künstliche Intelligenz steigert die Produktivität
18.06.26		Stock Market Today, June 18: QuantumScape Jumps After Teaming Up With Honda on Solid-State Battery Research Agreement
18.06.26		$1000 Invested In FTAI Aviation 10 Years Ago Would Be Worth This Much Today
18.06.26		Nvidia Ecosystem ETF Debuts, Offering Exposure To The AI Buildout
18.06.26		USA Rare Earth Now Has $3.5 Billion to Establish a "Mine-to-Magnet" Business That Is Crucial to National Security. Is the Stock a Buy Today?
18.06.26		Brookfield Is Launching Another Renewable Energy Company. Here's What Investors Need to Know.
18.06.26		If You Invested $1000 In NVIDIA Stock 5 Years Ago, You Would Have This Much Today
18.06.26		Anthropic Makes 'Fetch' Happen As New Claude Models Beat Human Teams on Robotics Planning Tasks
18.06.26		How Much Could $1,000 in SpaceX Stock Be Worth in 3 Years?
18.06.26		Today's Wordle Hints, Answer and Help for June 19, #1826
18.06.26		Here's How Much $100 Invested In STMicroelectronics 15 Years Ago Would Be Worth Today
18.06.26		A Reverse Stock Split Is Coming for Marqeta Shares. Should You Jump In Before It Happens?
18.06.26		3 Space Stocks to Buy Now That SpaceX Is Off the Table
18.06.26		What Does Appian CEO's Sale of 50,000 Shares for $1.2 Million Mean for Investors?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Javelin Minerals Spring Valley Acquisition a Luxury Real Estate Investment Fund Orangekloud Technolog a Dhillon Freight Carrier

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	19.06.2026 01:46
Kaufwert:	EUR
	Hinzufügen Speichern

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt Aktie

ISIN: KYG2851K1206

Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt Times and Sales (NAS)

Times and Sales

Analysen zu Drugs Made In America Acquisition II Corporation Cons of 1 Shs + 1 Rt

Weitere Meldungen